Print Services: Subscribe | Home Delivery Web: Mobile Edition |

 
Site Web Search powered by YAHOO!SEARCH
 
Silicon Valley 150
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Gilead Sciences, Inc. (NQ: GILD)
55.81 USD  +0.33 (+0.59%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Gilead Sciences, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Perfect Trade Setups, How to Play GILD, CPST, BMC and INFN
Today 12:00 EDT
from Marketwired News Releases
Don't Miss Gains in KO, EQR, GILD and CMCSA
May 24, 2013
from Marketwired News Releases
99.3% Return Seen to Date on SmarTrend Gilead Sciences Call (GILD)
May 24, 2013
from Comtex SmarTrend® News Briefs
Hot Movers on Health & Fitness Sector : ELN, MRK, JNJ, GILD
May 23, 2013
New York, NY -- (SBWIRE) -- 05/23/2013 -- The online Stock Consultant latest screen has found a biotech company that develops drugs for Alzheimer's and Parkinson's diseases Elan Corporation, PLC (ADR)... Read More
from SBWire - Latest Press Releases
Free Research Reports on GILD, MRK, ONCY and PFE Issued by the Bedford Report
May 23, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
The Reason It Trades, What's Moving ELN, DELL, GILD and KEY
May 23, 2013
from Marketwired News Releases
La Agencia Europea del Medicamento aprueba la solicitud de comercialización de sofosbuvir de Gilead para el tratamiento de la hepatitis C
May 22, 2013
from Business Wire Spanish
Gilead Sciences (GILD) Approaches New Upside Target of $57.45
May 22, 2013
from Comtex SmarTrend® News Briefs
EMA Approves MAA for Gilead's (GILD) Sofosbuvir
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8359487 for the full story. Read More
from StreetInsider.com News Articles
European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
May 21, 2013
from Business Wire News Releases
News Behind Insider Trading: American International Group, First Solar, Gilead Sciences, J.C. Penney, U.S. Bancorp, and Chesapeake Energy
May 21, 2013
from PR Newswire
Gilead Sciences, Inc. (NASDAQ:GILD) Investor Alert: Investigation over Possible Violations of Securities Laws
May 21, 2013
San Diego, CA -- (SBWIRE) -- 05/21/2013 -- An investigation on behalf of investors of Gilead Sciences, Inc. (NASDAQ:GILD) shares over potential securities laws violations by Gilead Sciences and certain... Read More
from SBWire - Latest Press Releases
Start Making Profits Now With AMAT, BMY, GILD and RENN
May 21, 2013
from Marketwired News Releases
Cramer's Watch List Ahead of Big Cancer Conference
May 20, 2013
The American Society of Clinical Oncology meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer. Read More
category BioMarin Pharmaceutical Inc , Biotechnology , Merck & Co Inc , and 13 more.
from CNBC.com News
Bayer says lung drug shows promise in prolonged trial
May 20, 2013
FRANKFURT, May 20 (Reuters) - Bayer said extended use of its experimental riociguat pill to treat a life-threatening form of high blood pressure in the lungs was shown to be safe and effective in a... Read More
category companyNews
from Reuters: Company News
Profitable Trading Secrets Revealed in GILD, NWSA, RF and MTG
May 18, 2013
from Marketwired News Releases
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
May 17, 2013
from Business Wire News Releases
UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8350777 for the full story. Read More
from StreetInsider.com News Articles
Analyst Moves: NOC, GM, GILD
May 17, 2013
This morning, Credit Suisse increased its price target on shares of Northrop Grumman (NOC) to $78 as additional buybacks will boost the stock. In the report, Credit Suisse also increased its EPS... Read More
category Stocks
from Market News Video
AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349940 for the full story. Read More
from StreetInsider.com News Articles
Lightning Round: Starbucks, Gilead & More
May 16, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. Read More
category Lightning Round , Starbucks Corp , Dominion Resources Inc , and 10 more.
from CNBC.com News
Gilead anuncia datos de respuesta del estudio de Fase 2 de idelalisib para leucemia linfática crónica no tratada con anterioridad
May 16, 2013
from Business Wire Spanish
Strategy Behind Our Success, We Get in Early: GILD, MCP, GM and DF
May 16, 2013
from Marketwired News Releases
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
May 15, 2013
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of... Read More
category NYSE:JNJ , NYSE:MRK , NASDAQ:PCYC , and 2 more.
from Forbes Real Time
Gilead Offers Response Data from Phase 2 Study of Idelalisib
May 15, 2013
Gilead Sciences, Inc. (Nasdaq: GILD ) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K delta,... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
May 15, 2013
from Business Wire News Releases
Experimental Gilead drug effective in early-stage leukemia trial
May 15, 2013
May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into... Read More
category companyNews
from Reuters: Company News
Medical Stocks Gaining Momentum (GILD, HALO, AFFY, AVEO)
May 15, 2013
New York, NY -- (SBWIRE) -- 05/15/2013 -- Gilead Sciences, Inc. (NASDAQ:GILD) shares rose 0.43% $ 56.49 while trading in range of $ 55.09 – 57.10 with average volume 12.93 million shares. GILD price to... Read More
from SBWire - Latest Press Releases
Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8340860 for the full story. Read More
from StreetInsider.com News Articles
In the Know, Smart Investing in FCX, GILD, AIG and BMY
May 15, 2013
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Copyright 2008 San Jose Mercury News
Help | Site Map | Advertise | Newsletters | Home Delivery | Copyright | About MediaNews Group | RSS | Ethics Policy

Privacy Policy  |   Site Map